Taiho Oncology, Inc.
5 products found
Taiho Oncology, Inc. products
Taiho - Inhibitor
S6K, AKT, RSK inhibitor for Solid Tumors PHASE 1.
Taiho - Tyrosine Kinase Inhibitor
Tyrosine Kinase Inhibitor of EGFR exon 20 insertion mutations. Non-Small Cell Lung Cancer (Phase 1/2) PHASE 2.
LONSURF - Thymidine-Based Nucleoside Analogue and Thymidine Phosphorylase Inhibitor
Colorectal cancer in combination with bevacizumab PHASE 3.
Futibatinib - Inhibitor
Tumors with specific FGFR aberrations: Solid tumors, Gastric cancer, Myelolymphoid neoplasms PHASE 2.
Taiho - Inhibitor
ERBB inhibitor for Solid Tumors PHASE 1.